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Abstract: Background: Obsessive compulsive personality disorder (OCPD) is commonly associated
with anxiety and mood disorders (AMDs), in which fatigue and executive dysfunction represent
key symptoms. Executive dysfunction has also been demonstrated in subjects with OCPD, and is
additionally found to be a cardinal feature of fatigue. This study aimed to investigate the associations
between fatigue, executive dysfunction, and OCPD in patients with AMDs. Methods: In this
cross-sectional study, 85 AMD patients (78% females, mean age 39± 11 years) were evaluated for OCPD
traits by using the observer-rated Compulsive Personality Assessment Scale. The Multidimensional
Fatigue Inventory-20 was used to measure different aspects of fatigue, and the Trail Making Test was
employed to assess executive functioning. The Hamilton rating scales were used to evaluate anxiety
and depression symptoms. Results: Controlling for potential confounders, there was a significant link
between OCPD and mental fatigue (OR, 1.27; 95% CI, 1.02 to 1.58; p = 0.033). No associations were
found between the presence of OCPD and other relevant fatigue characteristics, including general
fatigue, physical fatigue, reduced activity, and reduced motivation, as well as executive functions.
Conclusions: To the best of our knowledge, this study is the first to report associations between
OCPD and mental fatigue in patients with AMDs, suggesting mental fatigue as a clinically important
symptom when considering particular personality pathologies.
Keywords: obsessive compulsive personality; fatigue; mental exertion; cognitive/mental demand;
executive function; mood disorder; anxiety disorder
1. Introduction
Obsessive compulsive personality disorder (OCPD) is characterized by a chronic maladaptive
pattern of excessive perfectionism, preoccupation with orderliness and detail, cognitive rigidity,
and need for control [1,2]. It represents one of the most prevalent personality disorders, affecting
almost 8% of the general population worldwide [1,3]. OCPD is highly prevalent in various psychiatric
populations [4], including patients with anxiety and mood disorders (AMDs), where the prevalence
is reported to increase to around 25% [5–9], and is thought to signify a poor clinical outcome after
antidepressant treatment [10]. Yet, OCPD is still under-researched [11] and frequently under-diagnosed,
even in clinical populations [12]. To date, no evidence-based treatments have been established, though
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a possible therapeutic role for selective serotonin inhibitors or cognitive remediation therapies has
been proposed [13,14].
Perfectionism, a core symptom of OCPD, represents one of the key factors involved in the
development and maintenance of anxiety and depressive symptoms [15,16], as well as chronic
fatigue [17]. In fact, traits of OCPD are commonly associated with anxiety and depression [18],
disorders of which include fatigue as an intrinsic element.
Furthermore, several authors analyzing separate traits that have been attributed to OCPD, such as
workaholism [19–21] and perfectionism [8,17], suggest their possible association with fatigue. Due to the
tendency of “workaholic behavior” [12,21], people with OCPD are more prone to work-related fatigue,
which itself is associated with work-related rumination and poorer sleep quality [22]. Furthermore,
the perfectionism trait, which is part of OCPD conceptualization, is considered a pre-disposing
factor to persistent fatigue [17] due to increased mental activity and excessively high standards [23].
Taken together, the lack of recovery after work-related stress, together with excessive perfectionism,
may lead a person with OCPD to depletion of emotional resources, which may contribute to developing
chronic fatigue [24]. However, so far, no study has investigated the possibility of a specific association
between fatigue and OCPD.
It is well established that AMDs are associated with a broad spectrum of neurocognitive changes,
including significant executive dysfunction [25–32]. A meta-analysis by McDermott et al. [25] suggested
that increased severity of depression is linked with reduced cognitive performance, specifically in
the areas of episodic memory, executive functions, and processing speed. Another systematic
review by Lee et al. [27] reported poor neuropsychological performance in those with first-episode
major depressive disorder. Cognitive deficits are also present in patients with bipolar disorder,
as meta-analyzed by Depp et al. [28]. Similarly, cognitive impairment has also been found in those
with generalized anxiety disorder [26].
Nevertheless, the neurocognitive mechanisms underpinning OCPD are still under-researched.
In a recent study, executive dysfunction, particularly cognitive inflexibility (inflexible set shifting)
and impaired executive planning, was demonstrated in a group of subjects with OCPD [1] in a
non-clinical sample, excluding those with AMDs. Prior research has also reported executive dysfunction
in patients with obsessive compulsive disorder [33–35], which is a different yet often comorbid disorder
with OCPD, sharing conceptual and nosological similarities [12,36]. Prior research has also reported
executive dysfunction, specifically inflexible task switching (a component in set shifting), as a cardinal
feature of mental fatigue in a post-myocardial infarction population [37]. This was the first study to
clearly indicate an association between mental fatigue and executive functioning in this population [38].
Taken together, these findings suggest that a specific association may exist between OCPD,
executive impairment, and fatigue in patients with AMD that has thus far not been explored.
In this study, we aimed to investigate whether measures of mental fatigue and cognitive functioning
are associated with the presence of OCPD in a sample of patients with AMD. If such a relationship
were to be reliably demonstrated, the findings would be of clinical value, as clinicians would be alerted
to look for the presence of OCPD in patients presenting with AMDs characterized by excessive fatigue,
and could adapt the care plan accordingly.
2. Materials and Methods
2.1. Participants
This cross-sectional case–control study included 91 consecutive AMD patients attending an
outpatient stress disorder unit at the Palanga Clinic of the Neuroscience Institute, Lithuanian University
of Health Sciences. Six patients (7%) were unwilling to participate in the study. The final sample
consisted of 85 patients (78% females and 22% males) with a mean age of 39± 11 years. All study patients
had comorbid AMD diagnoses as follows: Major depressive episode, 71 patients (84%); dysthymia,
14 patients (17%); bipolar disorder, 5 patients (6%); generalized anxiety disorder, 37 patients (44%);
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panic disorder, 37 patients (44%); agoraphobia, 53 patients (62%); and social anxiety disorder, 30 patients
(35%) (Table 1). All patients received standard treatments for their AMDs according to their clinical needs.
The commonest medications used were selective serotonin reuptake inhibitors (SSRIs), benzodiazepines,
antipsychotics, and mirtazapine, taken either as a monotherapy or in various combinations. The amount
of medication used was similar in both groups; 25% of the OCPD group were not taking any medication
compared to 18.5% in the control group (p = 0.524) and there was no significant overuse of any
one type of medication or medication combination in the OCPD group compared to the controls
(see Supplementary Table S1). All of the patients received psychological–psychotherapeutic treatment
according to their problems, including individual psychological counseling, group psychotherapy,
dance/movement therapy, art therapy, and relaxation training.
Table 1. Baseline characteristics and cross-sectional clinical and cognitive measurements for the
study participants.
Total
(n = 85)
Age, mean ± SD 39.3 ± 11.2
Gender, n (%)
Men 19 (22.4)
Women 66 (77.6)
Education, n (%)
Tertiary education 24 (28.2)
College/university degree 61 (71.8)
Current medication use, n (%)
Antidepressants 59 (69.4)
Tranquilizers 34 (40.0)
Mood stabilizers 5 (6.0)
Neuroleptics 19 (22.4)
History of smoking, n (%) 19 (22.4)
Anxiety score as measured with the Hamilton Anxiety Rating Scale, mean ± SD 25.6 ± 9.4
Depression score as measured with the Hamilton Depression Rating Scale, mean ± SD 15.4 ± 6.8
Trail Making Test, mean ± SD
Test part A time (s) (cognitive processing speed) 26.8 ± 9.0
Test part B time (task switching) 67.5 ± 23.0
Derivative score test part B–test part A (s) (executive control) 40.7 ± 19.8
Fatigue as measured with the Multidimensional Fatigue Inventory-20, mean ± SD
General fatigue 16.2 ± 3.4
Physical fatigue 15.5 ± 3.7
Reduced activity 15.4 ± 4.1
Reduced motivation 14.6 ± 3.4
Mental fatigue 15.9 ± 3.8
Notes: Values are given in numbers (%) or mean ± standard deviation (SD).
2.2. Treatment Setting and Procedures
Sociodemographic, clinical, and psychological characteristics were evaluated during the first
three days of admission to the unit. Patients also completed a questionnaire, assessing subjectively
experienced fatigue symptoms and completed tests measuring cognitive functioning. The Lithuanian
Biomedical Research Ethics Committee (project identification code: Stresogen no.1, 25 February 2019)
approved the study protocol and each study participant gave informed consent before inclusion into
the study. The study was conducted in accordance with the Declaration of Helsinki.
2.3. Measures
Sociodemographic and clinical information, including diagnosis (as defined by The Mini
International Neuropsychiatric Interview) [38], medication use, and history of smoking, were collected.
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The presence and severity of OCPD traits were evaluated using the observer-rated Compulsive
Personality Assessment Scale (CPAS) [39]. Based on a semi-structured interview, each of the eight
Diagnostic Statistical Manual-5 (DSM-5) diagnostic criteria is scored on a scale of zero to four, and the
maximum total score of the CPAS is 32. Consistent with the DSM-5, we operationally defined a
diagnosis of OCPD as a score of three (severe) or four (very severe) on at least four of the CPAS items.
CPAS had acceptable internal reliability (Cronbach’s α = 0.75).
The Multidimensional Fatigue Inventory-20 (MFI-20) was used to assess general, physical,
and mental fatigue, reduced activity, and motivation [40,41]. Patients were asked about their
subjectively experienced fatigue during the past few days, rating the severity of symptoms from one
(no fatigue) to five (very fatigued). A higher overall score in each sub-scale indicates higher levels of
fatigue or reduced motivation. The MFI-20 had an adequate internal reliability (Cronbach’s α = 0.91).
The 14-item Hamilton Anxiety Scale (HAM-A) and the 17-item Hamilton Depression Scale
(HAM-D) were employed to measure symptoms of anxiety and depression [42–44]. The HAM-A
(Cronbach’s α = 0.86) and HAM-D (Cronbach’s α = 0.78) had adequate internal reliability.
The Trail Making Test parts A (TMTA) and B (TMTB) [45] measure cognitive processing speed,
flexible task switching, and executive control. In TMTA, numbers are presented in a random array and
participants have to connect these numbers in numerical order. In TMTB, participants are asked to
connect numbers and letters alternately in sequential (numeric and alphabetical) order. The total time
in seconds (s) for TMTA reflects cognitive processing speed, while TMTB measures task switching
ability. A derivative score for executive control is calculated by taking the scores of TMTA and
subtracting them from those of TMTB. The lower the TMTB–A score, the greater the participant’s
executive control ability.
2.4. Statistical Analyses
Statistical analyses were conducted using version 17.0 of the SPSS for Windows statistical package
(SPSS Inc, Chicago, IL, USA). Two-tailed Student’s t-tests or Fisher’s χ2 tests were applied to compare
fatigue and cognitive function, as well as sociodemographic and clinical characteristics in AMD patients
with and without OCPD. While exploring the possible associations between fatigue characteristics,
executive functioning, and OCPD, we used Benjamini–Hochberg adjustment for multiple comparisons
in relevant domains, setting a critical value for a false discovery rate of 0.15 (p = 0.03).
For the remaining associations, binary logistic regression analyses were performed to test
associations between OCPD, fatigue, and cognitive function, while controlling for possible
confounders, including symptoms of anxiety and depression, age, gender, education, medication use,
and smoking behavior.
3. Results
Baseline characteristics and cross-sectional case–control metrics are presented in Table 1.
The average Hamilton Anxiety Scale score was 26 ± 9, representing moderate anxiety [42], while the
average Hamilton Depression Scale score was 15 ± 7, suggesting moderate depression [43,44].
Almost one quarter (24%) of the AMD patients fulfilled the operational criteria for OCPD.
Our results show that the level of mental fatigue (though not other forms of fatigue) was higher
among OCPD patients than non-OCPD patients (−1.63; 95% CI, −3.08 to −0.17; p = 0.029). However,
there were no significant differences in terms of executive dysfunction in those with and without the
presence of OCPD features (all p-values ≥0.05) (Table 2).
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Table 2. Comparison of cognitive functioning and fatigue levels in patient groups with and without
obsessive compulsive personality disorder (OCPD) *.
Mean Difference
(95% CI) p-Value
Trail Making Test
Test part A time (s) (cognitive processing speed) −0.89 (−5.50; 3.73) 0.704
Test part B time (task switching) 6.19 (−5,52; 17.89) 0.296
Derivative score test part B–test part A (s) 7.07 (−2.97; 17.11) 0.165
(executive control)
Fatigue as measured with Multidimensional Fatigue Inventory-20
General fatigue −1.08 (−2.78; 0.63) 0.213
Physical fatigue −0.97 (−2.86; 0.92) 0.311
Reduced activity −1.15 (−3.22; 0.93) 0.275
Reduced motivation −1.70 (−3.39; −0.00) 0.050
Mental fatigue −1.63 (−3.08; −0.17) 0.029
Notes: * Defined operationally using the Compulsive Personality Assessment Scale; CI, confidence interval. p-Value
calculated by using Student’s t-tests for continuous variables.
The scores on the sociodemographic parameters and clinical characteristics did not show any
difference between two groups (all p-values ≥ 0.05).
After controlling for the symptoms of anxiety and depression, age, gender, education, medication
use, and smoking, mental fatigue remained significantly associated with OCPD diagnosis risk (OR, 1.27;
95% CI, 1.02 to 1.58; p = 0.033).
4. Discussion
Our exploratory analysis revealed that the presence of OCPD was significantly associated with
higher mental fatigue, but not other fatigue characteristics, in AMD patients, even after controlling
for possible covariates. However, executive control measures, reflecting processing speed and task
switching ability, were not significantly linked with the presence of OCPD.
Our findings show that after adjustment for possible confounding factors, including symptoms
of anxiety and depression, age, gender, education, medication use, and smoking, mental fatigue
is linked with the presence of OCPD, which is in line with previously published studies in
various populations [46,47]. However, the presence of OCPD was not associated with other fatigue
characteristics such as general fatigue, physical fatigue, reduced activity, and reduced motivation.
In 2015, Calvo and colleagues suggested that personality disorders, including OCPD, which was found
in 48.5% of the study sample, were more common in participants with chronic fatigue syndrome than
in individuals with no fatigue [24]. In contrast, other fatigue features, including general fatigue and
reduced motivation, might be symptoms influenced more by former Axis I disorders such as depression
or generalized anxiety disorder. It should be taken into account that in t-test comparisons, there was
only a trend for statistical significance of higher mental fatigue score in a group of individuals with
OCPD vs. a group of individuals without OCPD. However, this association remained after controlling
the results for other possible confounding factors. Thus, the presence of mental fatigue might be
a unique feature of individuals with OCPD. This reasoning was partially confirmed in a study by
Ruiter et al. (2012), where the presence of OCPD was also related to greater mental fatigue severity in
84 adults with chronic insomnia [46].
Mental fatigue is described as a psychobiological state influenced by prolonged periods of
demanding cognitive activity [48]. In our study, mental fatigue was assessed using an MFI-20 subscale
of four items—“When I am doing something, I can keep my thoughts on it,” “I can concentrate well,”
“It takes a lot of effort to concentrate on things,” and “My thoughts easily wander”—mainly reflecting
poor concentration and effort needed to maintain focus.
Interestingly, another study conducted by Pasquini and colleagues [47] reported that only when
OCPD was present did patients with obsessive compulsive disorder claim to experience higher mental
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fatigue in contrast to healthy controls. According to Calvo and colleagues, individuals with personality
disorders usually demonstrate maladaptive response to negative psychosocial stimuli, which may lead
to chronic mental stress [24]. Thus, OCPD may act as a predisposing factor to mental fatigue.
Another explanation may stem from the neurocognitive characteristics of OCPD, as extreme
perfectionism and cognitive rigidity, leading to the inflexible pursuit of high standards, the need to
exert mental and situational control, as well as workaholism and executive responsibility, may lead
a person to overestimate their mental capabilities and exhaust themselves. In fact, these are also
characteristics often attributed to patients with chronic fatigue syndrome [24].
Furthermore, as mentioned earlier, the current findings do not show significant links between
cognitive functioning and the presence of OCPD in patients with AMDs. The results differed from
a previously published study by Fineberg et al. [1] in those without AMDs. This recent study in a
student sample found that 21 non-clinical subjects with OCPD were significantly poorer in executive
planning as measured using the Stockings of Cambridge task [49] and the cognitive flexibility task as
measured on the intradimensional/extradimensional set shift, in contrast to 15 healthy controls without
OCPD [1]. However, on the contrary, in another study of 24 patients with traumatic brain injury [50],
executive functioning, as measured by the Wisconsin card sorting test, was not associated with the
presence of OCPD. The latter findings showing non-significant links between these two variables are
in line with our results.
Several explanations might underlie these inconsistent findings, such as methodological differences
(i.e., the use of different measures of cognitive function) and relatively small sample sizes across all
of the studies. The findings may also differ due to the distinct clinical characteristics ranging from
non-clinical subjects to patients with traumatic brain injury. As with fatigue, executive functioning
is known to be affected by anxiety and depression [51]. In our study, in particular, the presence of
anxiety and depression may have obscured any additional effect of OCPD on cognitive functioning.
Thus, the effect of the former Axis I disorders on executive functioning might be stronger than the
effect of personality traits. Therefore, these associations might be more apparent in studies comparing
the cognitive functioning of healthy controls vs. individuals with OCPD [51].
In contrast to Fineberg et al. [1], we used the TMT, which is considered to be a relatively shorter
and easier cognitive test, and might not be sensitive enough to reflect the complex neurocognitive
mechanisms of executive dysfunction in OCPD. Patients with OCPD, due to their conscientiousness
and greater concern for details, might have been better able to complete a test not requiring complex
cognitive skills in a short period of time. However, to confirm this assumption, further studies using
various cognitive function instruments are required.
Although these associations were found to be independent of major confounding factors, the exact
mechanisms linking mental fatigue with OCPD traits are still unknown. Thus, future research should
explore the possible role of mediating factors in this association, including the role of executive
functioning. A larger clinical sample and more complex neurocognitive measures are also needed to
make more accurate predictions. Further, investigation of mental fatigue in diverse groups of patients
is also recommended to confirm the current finding.
There are several limitations noteworthy of mention in this report. First, since this study was based
on a cross-sectional design, assumptions of causality must be made with caution. Second, patients
were recruited from a single clinic, which may have introduced selection bias into the results. It is also
worth mentioning that the number of subjects was relatively small. This was an exploratory study
where we used the Benjamini–Hochberg criterion, which is considered to be a liberal adjustment
method for correcting for multiple comparisons. However, in particular, this criterion allows to set a
false discovery rate, controlling for the expected proportion of significant findings that are false and
is a recommended alternative to Bonferroni-type adjustments in health studies [52]. Future research
should focus on obtaining a larger sample population of AMD patients in order to confirm the findings.
Finally, in the DSM-5, the presence of OCPD can be determined based on the classical as well as an
alternative models for personality disorders (AMPDs). In this study, we used the CPAS scale, which is
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based on the classical DSM-5 OCPD diagnostic approach. It was beyond our study scope to measure
OCPD within an AMPD framework. However, this limitation can be addressed in future studies.
These results suggest an important first step toward better understanding the links between
OCPD, executive functioning, and mental fatigue in patients with AMDs. However, the mechanism
by which these variables may interact still remains to be established with any degree of certainty in
future studies.
5. Conclusions
Overall, this study demonstrates that in patients with AMDs, mental fatigue, but not other fatigue
characteristics or executive functioning, is independently associated with the presence of OCPD. It is
also a first study to report that mental fatigue possibly represents a previously under-explored marker
of OCPD. Future research on this topic will help to further define the OCPD psychological profile,
which will assist with diagnosis and treatment. A greater understanding of our findings could lead to
a theoretical improvement in OCPD-related research, which is currently still under development.
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